Can you get tirzepatide from a compounding pharmacy?
Some pharmacies or clinics may supply compounded versions of medicines like tirzepatide (Mounjaro, Zepbound) and semaglutide (Ozempic, Wegovy) to patients, but the FDA has issued safety warnings about this practice. Concerns have risen over active ingredients, side effects and labeling of these compounded products.
Tirzepatide injection is only available as a prescription brand name product. It comes in pre-filled single-dose pens vials (Mounjaro) and / or single-dose pens (Zepbound), according to Eli Lilly, the manufacturer.
- Zepbound is approved by the FDA for weight loss in adults with obesity or who are overweight and have weight-related medical problems. Zepbound helps you to lose weight and maintain weight loss and should be combined with a reduced-calorie diet and exercise. It is also approved to treat moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity.
- Mounjaro is used to help lower blood sugar in adults with type 2 diabetes and is also used together with diet and exercise.
Some people may receive a prescription for compounded medicine because they need a special formulation, to help save costs, or due to a drug shortage in their area. According to the drug shortages list from the FDA, injectable prescription tirzepatide is now available commercially, although shortages have occurred with this product and others like it in the past.
Related: How does Zepbound help treat sleep apnea?
Is compounded tirzepatide safe?
The FDA does not review compounded versions of prescription medications, including tirzepatide, for safety, effectiveness or quality. In addition, Eli Lilly, the manufacturer of tirzepatide states that they cannot validate the safety or effectiveness of products claiming to contain tirzepatide that are not their branded product (brand names: Mounjaro and Zepbound).
Eli Lilly has stated that they have filed lawsuits to protect patient safety and stop the unlawful sales of compounded tirzepatide, a non-FDA approved and fraudulent product.
Semaglutide example
In May 2023 the FDA raised some concerns about another compounded incretin mimetic, semaglutide (Ozempic and Wegovy) from Novo Nordisk.
According to the FDA there have been reports of side effects (“adverse events”) in patients who have used compounded version of semaglutide, a drug similar to tirzepatide and used to treat patients with type 2 diabetes, for cardiovascular risk reduction, and for weight loss management.
The FDA also reported that some compounding pharmacies were using different salt forms of semaglutide as the active ingredient. These include semaglutide acetate and semaglutide sodium, products that are not approved by the FDA and are different from the active ingredients found in Ozempic or Wegovy.
There are no generic options for tirzepatide in the U.S. and the active ingredient for compounding is not available from the manufacturer.
Novo Nordisk is also pursuing legal action against compounding pharmacies for selling adulterated and misbranded compounded drugs claiming to contain semaglutide.
Related questions
- 6 Wegovy side effects you need to be aware of
- Ozempic Mounjaro Wegovy & Zepbound: Weight Loss Compared
- Wegovy vs Ozempic: Which is Right for You?
What exactly is drug compounding?
Drug compounding is a legal and a well-accepted practice in the United States, often done by licensed pharmacists or other healthcare providers. Drug compounding is the process of combining, mixing, or changing ingredients to create a medication specific for the needs of an individual patient.
A compounded version of an approved drug may be formulated if it meets certain conditions in the Federal Food, Drug and Cosmetic (FD&C) Act. For example, if an approved drug is in shortage, a compounded version can be legally prepared. However, compounded drugs are not FDA-approved, and the agency does not verify the safety or effectiveness of compounded drugs.
Compounded medications require a prescription from a healthcare provider. Licensed compounding pharmacies in the U.S. can legally prepare compounded medications when adhering to guidelines from the FDA and their State Board of Pharmacy. Patients should only obtain medicines from state-licensed pharmacies or facilities registered with the FDA.
However, concerns have been raised about some compounding practices in the past, including sterility and other quality issues.
What can patients do?
Speak to your healthcare provider about the availability of FDA-approved, prescription injectable tirzepatide (Mounjaro or Zepbound) in your area. If there is a shortage, discuss what options you have for the safe use of a prescription drug for your condition. The FDA states that a patient should not use a compounded product if an approved medication like Mounjaro or Zepbound is available.
If you think you have received counterfeit tirzepatide or accessed it from an unauthorized source, contact your healthcare provider. Counterfeit drugs may contain the wrong ingredients, too little or too much drug, dangerous compounds, or no active ingredient at all.
Patients and healthcare providers can also report counterfeit tirzepatide by calling Eli Lilly at 1-800-545-5979.
FDA also encourages health care professionals, patients, and compounders to report adverse events or quality problems with these or any medications to FDA’s MedWatch Adverse Event Reporting program.
This is not all the information you need to know about compounded tirzepatide for safe and effective use and does not take the place of your doctor’s directions. Discuss this information and any questions you have with your doctor or other health care provider.
References
- FDA Approves First Medication for Obstructive Sleep Apnea. US Food and Drug Administration (FDA). Dec. 28, 2024. Press Announcements. Accessed Dec. 23, 2024 at https://www.fda.gov/news-events/press-announcements/fda-approves-first-medication-obstructive-sleep-apnea
- Medications Containing Semaglutide Marketed for Type 2 Diabetes or Weight Loss. US Food and Drug Administration (FDA). October 31, 2023. Accessed Dec. 14, 2023 at https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/medications-containing-semaglutide-marketed-type-2-diabetes-or-weight-loss
- FDA Drug Shortages. US Food and Drug Administration (FDA). Accessed Dec. 14, 2023 https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm
- Lilly Statement on Mounjaro® (tirzepatide) Compounding Litigation. Press release. Sept. 19, 2023. Accessed Dec. 14, 2023 at https://investor.lilly.com/news-releases/news-release-details/lilly-statement-mounjaror-tirzepatide-compounding-litigation
- Zepbound (tirzepatide) prescribing information. Eli Lilly & Co. Indianapolis, IN. Accessed Dec. 14, 2023 at https://uspl.lilly.com/zepbound/zepbound.html#pi
- Mounjaro (tirzepatide) prescribing information. Eli Lilly & Co. Indianapolis, IN. Accessed Dec. 14, 2023 at https://uspl.lilly.com/mounjaro/mounjaro.html#s7
- Novo Nordisk takes additional legal actions to help protect US patients from potentially unsafe and ineffective compounded drugs claiming to contain semaglutide that are not FDA approved. Press release. Nov. 30, 2023. Accessed Dec. 14, 2023 at https://www.novomedlink.com/content/dam/novomedlink/semaglutide/November-30-2023-Company-Statement.pdf
Read next
How long to see weight loss results with Wegovy?
Weight loss may begin within the first 4 weeks of treatment with Wegovy, but the full effects of Wegovy may not be seen for several months or longer. In studies, after 68 weeks, 83% of people taking Wegovy lost 5% or more of their weight compared to 31% of people taking a placebo.
Continue reading
Do Ozempic, Wegovy, Mounjaro & Zepbound cause hair loss?
There’s no evidence that hair loss is a direct side effect of Ozempic, Wegovy, Mounjaro or Zepbound. Hair loss is more likely due to the stress of rapid weight loss on your body, which can lead to temporary shedding of hair over several months, a condition known as telogen effluvium. Continue reading
Which GLP-1 drug is best for weight loss?
Among the GLP-1 drugs currently available, tirzepatide and semaglutide stand out as the most effective for weight management. When choosing the best GLP-1 drug for weight loss, some things to consider include effectiveness, dosage formulation, frequency of administration, cost, and side effects. Continue reading
See also:
Related medical questions
- Does Ozempic cause muscle loss and how to prevent it?
- How do Zepbound and Wegovy compare?
- Ozempic Face: What causes it and how to prevent it?
- How do you get Wegovy covered by insurance?
- When is the best time of day to take Wegovy?
- Wegovy vs Mounjaro: Which works best for weight loss?
- Do GLP-1 drugs like Ozempic or Wegovy affect bone density?
- What is the cost of Wegovy?
- Is Ozempic covered by Medicare and Medicaid?
- Does Wegovy make you pee a lot or urine smell?
- How does Wegovy work for weight loss?
- Is Wegovy covered by Medicare?
- MariTide vs Wegovy or Zepbound: how do they compare?
- How can probiotics boost GLP-1 levels naturally?
- Saxenda vs Wegovy: Which weight loss drug is right for you?
- Can Ozempic and Wegovy cause eye blindness?
- Can Wegovy or Ozempic be used for heart failure?
- Semaglutide and liraglutide for alcohol use disorder (AUD)
- Wegovy coupon card: Do I qualify and how much can I save?
- What options are there for weight loss medications?
- What's the buzz on Ozempic and Wegovy?
- What is the natural Mounjaro recipe for weight loss?
- Mounjaro vs Ozempic: Which is right for you?
- Zepbound vs. Mounjaro: Comparison Guide for Weight Loss and Diabetes Treatment
- Why am I not losing weight on Mounjaro?
- How long does it take for Mounjaro to start working?
- Can you switch between Ozempic and Mounjaro?
- Mounjaro side effects you need to be aware of
- Mounjaro constipation: Why it happens and how to get relief?
- How does Mounjaro Work for Weight Loss?
Drug information
Related support groups
- Wegovy (48 questions, 113 members)
- Mounjaro (53 questions, 123 members)
- Zepbound (23 questions, 30 members)
- Tirzepatide (17 questions, 14 members)
- Weight Loss (Obesity/Overweight) (861 questions, 1,512 members)
- Diabetes, Type 2 (511 questions, 1,429 members)
- Cardiovascular Risk Reduction (101 questions, 28 members)
- Obstructive Sleep Apnea/Hypopnea Syndrome (27 questions, 56 members)
- Sleep Apnea (23 questions, 102 members)